Study: Xanthan Gum, A Staple In Gluten-Free Foods, Linked To Gut Inflammation

Common Food Thickener Xanthan Gum Caused Mild Gut Inflammation in Rats

Xanthan gum shows up in gluten-free bread, packaged sauces, and the thickened liquids given to people with swallowing difficulties. Food manufacturers rely on it because it smooths texture without altering taste. Now, however, a newly published rat study raises a pointed question. Could this common additive be quietly irritating the gut lining?

Researchers fed adult male rats three different amounts of xanthan gum over ten weeks and examined their colons afterward. Tissue analysis showed signs of inflammation across every dose group compared to untreated animals, with the clearest damage in the middle and high-dose groups. The doses modeled a range of realistic human exposure scenarios, from someone using xanthan gum in a restrictive gluten-free diet to someone relying on a xanthan gum-based thickener for every meal.

Published in PLOS ONE, the study was conducted entirely in rats, so it does not prove xanthan gum harms the human gut. But researchers argue it offers biological evidence consistent with concerns clinicians have raised for over a decade about this ingredient, particularly around a serious bowel condition in newborns.

Four Rat Groups, Doses Modeled on Real Human Exposure

Thirty-two adult male Wistar rats were split into four groups of eight. One group received a standard diet with no xanthan gum. The other three received increasing amounts mixed into their food, calculated using an FDA formula that converts human exposure into an equivalent animal dose: gluten-free product use, mild swallowing difficulty using a thickener in some meals, and moderate difficulty using it in every liquid and meal.

After ten weeks, researchers examined the lower colon under a microscope, counting immune cells and measuring inflammation severity on a standardized scale. They also tested colon tissue for specific proteins tied to inflammation and gut-wall integrity, and analyzed the bacterial makeup of stool samples through genetic sequencing.

Inflammation Markers Rose at Every Dose Tested

Under the microscope, rats that received xanthan gum at any dose showed more lymphocytes, a type of immune cell, infiltrating the colon wall compared to untreated rats. The middle and high-dose groups scored significantly higher on the researchers’ standardized inflammation scale.

Tissue samples showed higher levels of an inflammation marker called TNF-alpha and a barrier protein called Claudin-2 across all three treated groups, meaning the tissue itself looked more inflamed and more permeable the more xanthan gum the rats received. A second set of lab tests, which measured these same proteins a different way, found a messier pattern: only the lowest-dose group showed a clear rise in Claudin-2 and a related barrier protein, and TNF-alpha barely moved at all between groups. Two other barrier proteins showed little to no change anywhere.

Higher Claudin-2 has been linked in other research to a more permeable gut lining, sometimes called a leaky gut, a pattern that shows up in conditions like Crohn’s disease and necrotizing enterocolitis, a life-threatening bowel condition in premature infants. That said, the researchers didn’t directly test whether anything actually crossed into the rats’ bloodstream. Claudin-2 is a marker connected to permeability, not proof that it happened.

None of the xanthan gum groups showed changes in body weight, fat, blood sugar, or cholesterol. The gut-level changes were happening quietly, with none of the usual warning signs.

Only the Highest Dose Shifted Gut Bacteria

Firmicutes and Bacteroidetes, the two broadest bacterial groups in the rats’ guts, stayed stable across all groups, along with their overall balance and diversity. Xanthan gum did not wipe out bacterial variety wholesale.

At the highest dose, however, a rare bacterial group increased significantly compared to the control and lowest-dose groups. Researchers also found correlations between certain gut bacteria and the barrier and inflammation proteins measured in the study, suggesting the bacterial shifts and the tissue changes may be connected, though the relationship needs further study to sort out cause and effect.

Findings Echo a Decade-Old Warning About Infant Feeding

In 2011, the FDA warned against using a xanthan gum-based thickener in premature infants after it was linked to necrotizing enterocolitis, and its MedWatch program has tracked related cases since. Concern has since broadened to dysphagic patients, frail older adults, and others who rely on xanthan gum-thickened foods daily.

Its authors describe their results as confirming, in an animal model, the clinical hypothesis linking xanthan gum to that infant bowel condition. That’s a strong claim for a study conducted in adult rats rather than infants, and it reflects the authors’ own interpretation rather than an established fact about human health.

A separate case study cited by the authors found xanthan gum reduced the effectiveness of voglibose, a diabetes medication. That finding involves one drug, not prescription medications broadly, though it raises a narrower question worth watching for patients who depend on precise dosing while using thickeners.

This study used only male rats, examined just the colon, and involved a relatively small sample of eight animals per group. Translating these results directly to human health remains uncertain, and the authors call for further research bridging animal findings and clinical care. For now, the rat data adds a concrete signal to a question clinicians have debated for years: whether an ingredient meant to make food safer to swallow might be quietly working against the gut it passes through.

---

Disclaimer: This article reports on findings from an animal study and is intended for general informational purposes. It is not medical advice. Anyone with questions about food additives, swallowing difficulties, or digestive health should talk to a qualified healthcare provider.

---

---